Vindoline is a precursor of compound vinblastine. Vindoline was also used to synthesize vinorelbine, antitumor plant is an important intermediate.

The global Vindoline market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Vindoline volume and value at global level, regional level and company level. From a global perspective, this report represents overall Vindoline market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Vindoline in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Vindoline manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pierre Fabre
Minakem
Guangzhou Hanfang Pharmaceutical
Hainan Vinca Biological Medicine Technology
Guangzhou Person Pharmaceutical
Hainan Yueyang Biotechnology
Hubei Honch Pharmaceutical
Vinkem
Hansoh

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
0.98
Other

Segment by Application
Vinblastine Synthesis
Vinorelbine synthesis